Literature DB >> 34169467

Clearing the Haze: Navigating Corneal Refractive Surgery in Patients with Posterior Polymorphous Corneal Dystrophy.

Majid Moshirfar1,2,3, Alyson N Tukan4, Nour Bundogji4.   

Abstract

Posterior polymorphous corneal dystrophy (PPCD) is a corneal disorder of the endothelium and Descemet's membrane. Although reports of corneal refractive surgery including laser-assisted in situ keratomileusis (LASIK), photorefractive keratectomy (PRK), and small incision lenticule extraction (SMILE) in PPCD are minimal, these procedures have been shown to be safe and effective in this patient population. Proceeding with corneal refractive surgery in eyes with PPCD raises concerns regarding corneal integrity, including long-term biomechanical instability, risk of ectasia, endothelial cell loss, disease progression, and corneal decompensation. Thus, LASIK, PRK, and SMILE should be considered with caution. This commentary explores the patient characteristics associated with favorable surgical outcomes and factors that weigh against proceeding with refractive surgery.

Entities:  

Keywords:  Ectasia; Endothelial cell density; LASIK; PPCD; PPMD; PRK; Refractive surgery; SMILE

Year:  2021        PMID: 34169467     DOI: 10.1007/s40123-021-00364-z

Source DB:  PubMed          Journal:  Ophthalmol Ther


  11 in total

1.  Management of long-standing partially torn and flipped laser in situ keratomileusis flaps.

Authors:  Jin Sun Kim; Byunghoon Chung; Taekjune Lee; Woon Cho Kim; Tae-im Kim; Eung Kweon Kim
Journal:  J Cataract Refract Surg       Date:  2014-12-20       Impact factor: 3.351

2.  IC3D classification of corneal dystrophies--edition 2.

Authors:  Jayne S Weiss; Hans Ulrik Møller; Anthony J Aldave; Berthold Seitz; Cecilie Bredrup; Tero Kivelä; Francis L Munier; Christopher J Rapuano; Kanwal K Nischal; Eung Kweon Kim; John Sutphin; Massimo Busin; Antoine Labbé; Kenneth R Kenyon; Shigeru Kinoshita; Walter Lisch
Journal:  Cornea       Date:  2015-02       Impact factor: 2.651

3.  Classification of posterior polymorphous corneal dystrophy as a corneal ectatic disorder following confirmation of associated significant corneal steepening.

Authors:  Anthony J Aldave; Lydia B Ann; Ricardo F Frausto; Catherine K Nguyen; Fei Yu; Irving M Raber
Journal:  JAMA Ophthalmol       Date:  2013-12       Impact factor: 7.389

4.  Bacillaemia and bone marrow involvement in leprosy.

Authors:  R Sen; P K Sehgal; U Singh; M S Yadav; S D Chaudhary; R Sikka
Journal:  Indian J Lepr       Date:  1989-10

5.  Posterior polymorphous corneal dystrophy: a disease characterized by epithelial-like endothelial cells which influence management and prognosis.

Authors:  J H Krachmer
Journal:  Trans Am Ophthalmol Soc       Date:  1985

6.  Photorefractive keratectomy in posterior polymorphous dystrophy with vesicular and band subtypes.

Authors:  Kraig S Bower; Edward W Trudo; Denise S Ryan; Rose K Sia; Michael J Mines; Richard D Stutzman; Keith J Wroblewski
Journal:  J Cataract Refract Surg       Date:  2011-06       Impact factor: 3.351

7.  The corneal endothelium after myopic excimer laser photorefractive keratectomy.

Authors:  F Carones; R Brancato; E Venturi; A Morico
Journal:  Arch Ophthalmol       Date:  1994-07

8.  Small-incision lenticule extraction in posterior polymorphic corneal dystrophy.

Authors:  Jin Hyoung Park; Jae Hyun Lee; Hyung Jin Koo
Journal:  J Cataract Refract Surg       Date:  2016-05       Impact factor: 3.351

9.  Endothelial cell density in children with posterior polymorphous corneal dystrophy: a longitudinal case-control study.

Authors:  Simon Sheung Man Fung; Hamza Sami; Ali El Hamouly; Dishay Jiandani; Sara Williams; Kamiar Mireskandari; Asim Ali
Journal:  Eye (Lond)       Date:  2021-02-19       Impact factor: 3.775

10.  ZEB1 insufficiency causes corneal endothelial cell state transition and altered cellular processing.

Authors:  Ricardo F Frausto; Doug D Chung; Payton M Boere; Vinay S Swamy; Huong N V Duong; Liyo Kao; Rustam Azimov; Wenlin Zhang; Liam Carrigan; Davey Wong; Marco Morselli; Marina Zakharevich; E Maryam Hanser; Austin C Kassels; Ira Kurtz; Matteo Pellegrini; Anthony J Aldave
Journal:  PLoS One       Date:  2019-06-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.